Systematic review and meta-analysis on the adverse events of rimonabant treatment: Considerations for its potential use in hepatology

BACKGROUND: The cannabinoid-1 receptor blockers have been proposed in the management of obesity and obesity-related liver diseases (fatty liver as NAFLD or NASH). Due to increasing number of patients to be potentially treated and the need to assess the advantage of this treatment in terms of risk/be...

Descripción completa

Detalles Bibliográficos
Autores principales: Chavez-Tapia, Norberto C, Tellez-Avila, Felix I, Bedogni, Giorgio, Crocè, Lory S, Masutti, Flora, Tiribelli, Claudio
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2009
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763866/
https://www.ncbi.nlm.nih.gov/pubmed/19818116
http://dx.doi.org/10.1186/1471-230X-9-75

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2763866/
https://www.ncbi.nlm.nih.gov/pubmed/19818116
http://dx.doi.org/10.1186/1471-230X-9-75

Ejemplares similares